The metabolomics services market is expected to reach US$ 1,895.14 million by 2028 from US$ 501.24 million in 2021; it is estimated to grow at a CAGR of 20.9% during 2021-2028.
The emerging markets in regions such as the Middle East, Africa, and Asia Pacific are creating significant opportunities for the key market players to expand their businesses. The majority of players concentrate on developing markets, such as India and China, owing to the huge populations, including a large number of people suffering from chronic diseases. With the rising production costs, healthcare companies are striving to produce sufficient revenues to meet the demands of their investors.
Consumer expectations from diagnostic processes are growing with advancements in biotechnology. Moreover, these developments are encouraging the introduction of more analytical systems and facilitating the shift toward personalized medicine. Infectious disease testing, molecular oncology, and pharmacogenomics are among the high-potential segments in emerging countries. Various players in the industry have been investing significant shares of their revenues in R&D activities to develop better and advanced products and technologies for the healthcare sector. The Asia Pacific metabolomics services market is expected to grow at the fastest CAGR during the forecast period due to the presence of significant biopharmaceutical companies in countries such as Japan and the growing number of local companies in countries such as China and India. Further, the growing prevalence of cancer and other chronic diseases is likely to boost the market growth in the coming years.
The global metabolomics services market, based on service type, has been segmented into targeted metabolomics service, and untargeted metabolomics service. The targeted metabolomics service segment is likely to hold the largest share of the market in 2021. Moreover, the targeted metabolomics service segment is anticipated to register the highest CAGR in the market during the forecast period, due to their incumbent usage, high volume consumption, and product innovation.
The global metabolomics services market, based on application is segmented into pharmaceutical and biotechnology industry, agritech, environment. In 2021, the pharmaceutical and biotechnology industry segment is likely to hold the largest share of the market. Moreover, the segment is also expected to witness growth in its demand at a fastest CAGR of 21.6% during 2021 to 2028, owing to the rise in the detection and diagnosis of various medical conditions across the globe.
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH); National Healthcare Service (NHS); Centers for Disease Control and Prevention (CDC); National Chronic Kidney Disease; National Center for Biotechnology Information; National Institute of Diabetes and Digestive and Kidney Diseases; United Nations (UN) Global Population Prospects; National Statistics Institute; and World Health Organization (WHO) are among the major secondary sources referred to while preparing the report on the metabolomics services market.Reasons to Buy
The emerging markets in regions such as the Middle East, Africa, and Asia Pacific are creating significant opportunities for the key market players to expand their businesses. The majority of players concentrate on developing markets, such as India and China, owing to the huge populations, including a large number of people suffering from chronic diseases. With the rising production costs, healthcare companies are striving to produce sufficient revenues to meet the demands of their investors.
Consumer expectations from diagnostic processes are growing with advancements in biotechnology. Moreover, these developments are encouraging the introduction of more analytical systems and facilitating the shift toward personalized medicine. Infectious disease testing, molecular oncology, and pharmacogenomics are among the high-potential segments in emerging countries. Various players in the industry have been investing significant shares of their revenues in R&D activities to develop better and advanced products and technologies for the healthcare sector. The Asia Pacific metabolomics services market is expected to grow at the fastest CAGR during the forecast period due to the presence of significant biopharmaceutical companies in countries such as Japan and the growing number of local companies in countries such as China and India. Further, the growing prevalence of cancer and other chronic diseases is likely to boost the market growth in the coming years.
The global metabolomics services market, based on service type, has been segmented into targeted metabolomics service, and untargeted metabolomics service. The targeted metabolomics service segment is likely to hold the largest share of the market in 2021. Moreover, the targeted metabolomics service segment is anticipated to register the highest CAGR in the market during the forecast period, due to their incumbent usage, high volume consumption, and product innovation.
The global metabolomics services market, based on application is segmented into pharmaceutical and biotechnology industry, agritech, environment. In 2021, the pharmaceutical and biotechnology industry segment is likely to hold the largest share of the market. Moreover, the segment is also expected to witness growth in its demand at a fastest CAGR of 21.6% during 2021 to 2028, owing to the rise in the detection and diagnosis of various medical conditions across the globe.
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH); National Healthcare Service (NHS); Centers for Disease Control and Prevention (CDC); National Chronic Kidney Disease; National Center for Biotechnology Information; National Institute of Diabetes and Digestive and Kidney Diseases; United Nations (UN) Global Population Prospects; National Statistics Institute; and World Health Organization (WHO) are among the major secondary sources referred to while preparing the report on the metabolomics services market.Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the metabolomics services market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global metabolomics services market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 The Publisher's Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Metabolomics Services Market - By Service Type
1.3.2 Global Metabolomics Services Market - By Application
1.3.3 Global Metabolomics Services Market - By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Metabolomics Services Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East And Africa PEST Analysis
4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion
5. Metabolomics Services Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidences of Cancer
5.1.2 Increasing Adoption of Metabolomics and Investments by Market Players
5.2 Market Restraints
5.2.1 High Cost of Tools, Instruments, and Usage
5.3 Market Opportunities
5.3.1 Development Opportunities in Emerging Countries
5.4 Future Trends
5.4.1 Use of Artificial Intelligence (AI) and Biomarkers in Biomarker-Related Analysis and Personalized Therapy
5.5 Impact Analysis
5.6 Opportunities for Contract Research (CR)
5.7 Opportunities for Supplies of Consumables
5.8 Opportunities for Commercialization of Disease Biomarkers
6. Metabolomics Services Market- Global Analysis
6.1 Global Metabolomics Services Market Revenue Forecast and Analysis
6.2 Global Metabolomics Services Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Metabolomics Services Market Revenue and Forecasts To 2028- by Service Type
7.1 Overview
7.2 Global Metabolomics Services Market, By Service Type 2021 & 2028 (%)
7.3 Targeted Metabolomics Service
7.3.1 Overview
7.3.2 Targeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Untargeted Metabolomics Service
7.4.1 Overview
7.4.2 Untargeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
8. Metabolomics Services Market Revenue and Forecasts To 2028 - Application
8.1 Overview
8.2 Global Metabolomics Services Market Share by Application 2021 & 2028 (%)
8.3 Pharmaceutical and Biotechnology Industry
8.3.1 Overview
8.3.2 Pharmaceutical and Biotechnology Industry: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.1 Biomarker Discovery
8.3.2.1.1 Overview
8.3.2.1.2 Biomarker Discovery: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.2 Toxicological Testing
8.3.2.2.1 Overview
8.3.2.2.2 Toxicological Testing: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.3 Drug Discovery
8.3.2.3.1 Overview
8.3.2.3.2 Drug Discovery: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.4 Others
8.3.2.4.1 Overview
8.3.2.4.2 Others: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Agritech
8.4.1 Overview
8.4.2 Agritech: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Environment
8.5.1 Overview
8.5.2 Environment: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
9. Metabolomics Services Market Revenue and Forecasts to 2028 - Geographical Analysis
9.1 North America: Metabolomics Services Market
9.1.1 Overview
9.1.2 North America: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
9.1.3 North America: Metabolomics Services Market, by Service Type, 2019-2028 (USD Million)
9.1.4 North America: Metabolomics Services Market, by Application, 2019-2028 (USD Million)
9.1.4.1 North America: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry, 2019-2028 (USD Million)
9.1.5 North America: Metabolomics Services Market, by Country, 2021 & 2028 (%)
9.1.5.1 US: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
9.1.5.1.1 US: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
9.1.5.1.2 US: Metabolomics Services Market, by Service Type, 2019-2028 (USD Million)
9.1.5.1.3 US: Metabolomics Services Market, by Application, 2019-2028 (USD Million)
9.1.5.1.3.1 US: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry, 2019-2028 (USD Million)
9.1.5.2 Canada: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
9.1.5.2.1 Canada: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
9.1.5.2.2 Canada: Metabolomics Services Market, by Service Type, 2019-2028 (USD Million)
9.1.5.2.3 Canada: Metabolomics Services Market, by Application, 2019-2028 (USD Million)
9.1.5.2.3.1 Canada: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry, 2019-2028 (USD Million)
9.1.5.3 Mexico: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
9.1.5.3.1 Mexico: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
9.1.5.3.2 Mexico: Metabolomics Services Market, by Service Type, 2019-2028 (USD Million)
9.1.5.3.3 Mexico: Metabolomics Services Market, by Application, 2019-2028 (USD Million)
9.1.5.3.3.1 Mexico: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry, 2019-2028 (USD Million)
9.2 Europe: Metabolomics Services Market
9.2.1 Overview
9.2.2 Europe: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
9.2.3 Europe: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
9.2.4 Europe: Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
9.2.4.1 Europe: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
9.2.5 Europe: Metabolomics Services Market, by Country, 2021 & 2028(%)
9.2.5.1 Germany: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.1.1 Germany: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.1.2 Germany: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
9.2.5.1.3 Germany: Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
9.2.5.1.3.1 Germany: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
9.2.5.2 France: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.2.1 France: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.2.2 France: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
9.2.5.2.3 France: Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
9.2.5.2.3.1 France: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
9.2.5.3 UK: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.3.1 UK: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.3.2 UK: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
9.2.5.3.3 UK: Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
9.2.5.3.3.1 UK: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
9.2.5.4 Italy: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.4.1 Italy: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.4.2 Italy: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
9.2.5.4.3 Italy: Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
9.2.5.4.3.1 Italy: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
9.2.5.5 Spain: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.5.1 Spain: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.5.2 Spain: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
9.2.5.5.3 Spain: Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
9.2.5.5.3.1 Spain: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
9.2.5.6 Rest of Europe: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.6.1 Rest of Europe: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.6.2 Rest of Europe: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
9.2.5.6.3 Rest of Europe: Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
9.2.5.6.3.1 Rest of Europe: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
9.3 Asia Pacific Metabolomics Services Market Revenue and Forecasts To 2028
9.3.1 Overview
9.3.2 Asia Pacific Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.3 Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.3.4 Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.3.4.1 Asia Pacific: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
9.3.5 Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Country (%)
9.3.5.1 Japan: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5.1.1 Overview
9.3.5.1.2 Japan: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5.1.3 Japan: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.3.5.1.4 Japan: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.3.5.1.4.1 Japan: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
9.3.5.2 China: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5.2.1 Overview
9.3.5.2.2 China: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5.2.3 China: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.3.5.2.4 China: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.3.5.2.4.1 . China: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
9.3.5.3 India Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5.3.1 Overview
9.3.5.3.2 India: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5.3.3 India: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.3.5.3.4 India: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.3.5.3.4.1 India: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
9.3.5.4 South Korea: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5.4.1 Overview
9.3.5.4.2 South Korea: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5.4.3 South Korea: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.3.5.4.4 South Korea: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.3.5.4.4.1 South Korea: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
9.3.5.5 Australia: Metabolomics Services Market Revenue and Forecasts to 2028(US$ Mn)
9.3.5.5.1 Overview
9.3.5.5.2 Australia: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5.5.3 Australia: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.3.5.5.4 Australia: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.3.5.5.4.1 Australia: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
9.3.5.6 Rest of Asia Pacific: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
9.3.5.6.1 Overview
9.3.5.6.2 Rest of Asia Pacific: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
9.3.5.6.3 Rest of Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.3.5.6.4 Rest of Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.3.5.6.4.1 Rest of Asia Pacific: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
9.4 Middle East & Africa Metabolomics Services Market Revenue and Forecasts To 2028
9.4.1 Overview
9.4.2 Middle East & Africa Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.4.3 Middle East & Africa: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.4.4 Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.4.4.1 Middle East & Africa: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
9.4.5 Middle East & Africa Metabolomics Services Market Revenue and Forecasts to 2028, By Country (%)
9.4.5.1 UAE: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.4.5.1.1 Overview
9.4.5.1.2 UAE: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.4.5.1.3 UAE: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.4.5.1.4 UAE: Metabolomics Services Market Revenue and Forecasts To 2028, By Application (US$ Mn)
9.4.5.1.4.1 UAE: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
9.4.5.2 Saudi Arabia: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.4.5.2.1 Overview
9.4.5.2.2 Saudi Arabia: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.4.5.2.3 Saudi Arabia: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.4.5.2.4 Saudi Arabia: Metabolomics Services Market Revenue and Forecasts To 2028, By Application (US$ Mn)
9.4.5.2.4.1 Saudi Arabia: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
9.4.5.3 South Africa: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.4.5.3.1 Overview
9.4.5.3.2 South Africa Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.4.5.3.3 South Africa: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.4.5.3.4 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Application (US$ Mn)
9.4.5.3.4.1 South Africa: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
9.4.5.4 Rest of Middle East and Africa: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.4.5.4.1 Overview
9.4.5.4.2 Rest of Middle East and Africa: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.4.5.4.3 Rest of Middle East & Africa: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.4.5.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts To 2028, By Application (US$ Mn)
9.4.5.4.4.1 Rest of Middle East and Africa: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
9.5 South And Central America Metabolomics Services Market Revenue and Forecasts To 2028
9.5.1 Overview
9.5.2 South and Central America Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.3 South and Central America Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type(US$ Mn)
9.5.4 South and Central America: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.5.4.1 South and Central America: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
9.5.5 South and Central America Metabolomics Services Market Revenue and Forecasts to 2028, By Country (%)
9.5.5.1 Argentina Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.5.1.1 Overview
9.5.5.1.2 Argentina Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.5.1.3 Argentina Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type(US$ Mn)
9.5.5.1.4 Argentina: Metabolomics Services Market Revenue and Forecasts To 2028, By Application (US$ Mn)
9.5.5.1.4.1 Argentina: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
9.5.5.2 Brazil: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.5.2.1 Overview
9.5.5.2.2 Brazil: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.5.2.3 Brazil: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.5.5.2.4 Brazil: Metabolomics Services Market Revenue and Forecasts To 2028, By Application (US$ Mn)
9.5.5.2.4.1 Brazil: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
9.5.5.3 Rest of South and Central America: Metabolomics Services Market- Revenue and Forecast to 2028 (USD Mn)
9.5.5.3.1 Overview
9.5.5.3.2 Rest of South and Central America: Metabolomics Services Market- Revenue and Forecast to 2028 (USD Mn)
9.5.5.3.3 Rest of South & Central America: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type(US$ Mn)
9.5.5.3.4 Rest of South & Central America: Metabolomics Services Market Revenue and Forecasts To 2028, By Application (US$ Mn)
9.5.5.3.4.1 Rest of South and Central America: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Metabolomics Services Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Metabolomics Services Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 BASF SE
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 TMIC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Creative Proteomics
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 BGI
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 RTI International
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Afekta Technologies Ltd.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Fred Hutchinson Cancer Research Center
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 West Coast Metabolomics Center
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Molecular You
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Metabolon, Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 biocrates life sciences ag
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Chenomx Inc.
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
12.13 C-CAMP
12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 Financial Overview
12.13.5 SWOT Analysis
12.13.6 Key Developments
12.14 metaSysX
12.14.1 Key Facts
12.14.2 Business Description
12.14.3 Products and Services
12.14.4 Financial Overview
12.14.5 SWOT Analysis
12.14.6 Key Developments
12.15 MS-Omics
12.15.1 Key Facts
12.15.2 Business Description
12.15.3 Products and Services
12.15.4 Financial Overview
12.15.5 SWOT Analysis
12.15.6 Key Developments
13. Appendix
13.1 About The Publisher
13.2 Glossary of Terms
List of Tables
Table 1. R&D Investments by Major Pharmaceutical Companies
Table 2. North America Metabolomics Services Market, by Service Type- Revenue and Forecast to 2028 (USD Million)
Table 3. North America Metabolomics Services Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 4. North America Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry- Revenue and Forecast to 2028 (USD Million)
Table 5. US Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
Table 6. US Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 7. US Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 8. Canada Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 14. Europe: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
Table 15. Europe: Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 16. Europe: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 17. Germany: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
Table 18. Germany: Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 19. Germany: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 20. France: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
Table 21. France: Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 22. France: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
Table 23. UK: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
Table 24. UK: Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 25. UK: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 26. Italy: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
Table 27. Italy: Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 28. Italy: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 29. Spain: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
Table 30. Spain: Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 31. Spain: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 32. Rest of Europe: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of Europe: Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 34. Rest of Europe: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 35. Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 36. Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 37. Asia Pacific: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 38. Japan: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 39. Japan: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 40. Japan: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 41. China: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 42. China: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 43. China: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 44. India: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 45. India: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 46. India: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 47. South Korea: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 48. South Korea: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 49. South Korea: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 50. Australia: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 51. Australia: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 52. Australia: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 53. Rest of Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 54. Rest of Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 55. Rest of Asia Pacific: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 56. Middle East & Africa: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 57. Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 58. Middle East & Africa: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 59. UAE: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 60. UAE: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 61. UAE: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 62. Saudi Arabia: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 63. Saudi Arabia: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 64. Saudi Arabia: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 65. South Africa Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 66. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 67. South Africa: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 68. Rest of Middle East & Africa: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 69. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 70. Rest of Middle East and Africa: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 71. South and Central America Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type(US$ Mn)
Table 72. South and Central America: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 73. South and Central America: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 74. Argentina Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type(US$ Mn)
Table 75. Argentina: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 76. Argentina: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 77. Brazil: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 78. Brazil: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 79. Brazil: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 80. Rest of South & Central America: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type(US$ Mn)
Table 81. Rest of South & Central America: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 82. Rest of South and Central America: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
Table 83. organic Developments Done By Companies
Table 84. Inorganic Developments Done By Companies
Table 85. Glossary of Terms, Metabolomics Services MarketList of Figures
Figure 1. Metabolomics Services Market Segmentation
Figure 2. Metabolomics Services Market, By Region
Figure 3. Global Metabolomics Services Market Overview
Figure 4. Silicone Segment Held Largest Share of Type Segment in Metabolomics Services Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Metabolomics Services Market, by Geography (US$ Million)
Figure 7. Global Metabolomics Services Market- Leading Country Markets (USD Million)
Figure 8. Global Metabolomics Services Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East And Africa : PEST Analysis
Figure 13. South And Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Impact Analysis of Drivers and Restraints Pertaining to Metabolomics Services Market
Figure 16. Global Metabolomics Services Market- Revenue Forecast and Analysis - 2021- 2028
Figure 17. Global Metabolomics Services Market- By Geography Forecast and Analysis - 2021- 2028
Figure 18. Market Positioning of Key Players in Global Metabolomics Services Market
Figure 19. Global Metabolomics Services Market, by Service Type 2021 & 2028 (%)
Figure 20. Targeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. Untargeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. Global Metabolomics Services Market Share by Application 2021 & 2028 (%)
Figure 23. Pharmaceutical and Biotechnology Industry: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 24. Biomarker Discovery: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 25. Toxicological Testing: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 26. Drug Discovery: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 27. Others : Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 28. Agritech: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 29. Environment: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 30. North America: Metabolomics Services Market, by Key Country - Revenue (2021) (USD Million)
Figure 31. North America Metabolomics Services Market Revenue and Forecast to 2028 (USD Million)
Figure 32. North America: Metabolomics Services Market, by Country, 2021 & 2028 (%)
Figure 33. US: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
Figure 34. Canada: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
Figure 35. Mexico: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
Figure 36. Europe: Metabolomics Services Market, by Key Country - Revenue (2021) (USD Million)
Figure 37. Europe: Metabolomics Services Market Revenue and Forecast to 2028 (USD Million)
Figure 38. Europe: Metabolomics Services Market, by Country, 2021 & 2028 (%)
Figure 39. Germany: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
Figure 40. France: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
Figure 41. UK: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
Figure 42. Italy: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
Figure 43. Spain: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
Figure 44. Rest of Europe: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
Figure 45. Asia Pacific Metabolomics Services Market Overview, by Country (2021)
Figure 46. Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 47. Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Country (%)
Figure 48. Japan: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 49. China: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 50. India: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 51. South Korea: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 52. Australia: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 53. Rest of Asia Pacific: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
Figure 54. Middle East & Africa Metabolomics Services Market Revenue Overview, by Country, 2021 (US$ Mn)
Figure 55. Middle East & Africa Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 56. Middle East & Africa Metabolomics Services Market Revenue and Forecasts to 2028, By Country (%)
Figure 57. UAE: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 58. Saudi Arabia: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 59. South Africa: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 60. Rest of Middle East and Africa: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 61. South and Central America Metabolomics Services Market Revenue Overview, by Country, 2021 (US$ Mn)
Figure 62. South and Central America Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 63. South and Central America Metabolomics Services Market Revenue and Forecasts to 2028, By Country (%)
Figure 64. Argentina Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 65. Brazil: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 66. Rest of South and Central America: Metabolomics Services Market- Revenue and Forecast to 2028 (USD Mn)
Figure 67. Impact of COVID-19 Pandemic in North American Country Markets
Figure 68. Impact of COVID-19 Pandemic in European Country Markets
Figure 69. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 70. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 71. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets
Figure 72. Growth Strategies Done by the Companies in the Market, (%)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- BASF SE
- TMIC
- Creative Proteomics
- BGI
- RTI International
- Afekta Technologies Ltd.
- Fred Hutchinson Cancer Research Center
- West Coast Metabolomics Center
- Molecular You
- Metabolon, Inc.
- biocrates life sciences ag
- Chenomx Inc.
- C-CAMP
- metaSysX
- MS-Omics
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 171 |
| Published | October 2021 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 501.24 Million |
| Forecasted Market Value ( USD | $ 1895.14 Million |
| Compound Annual Growth Rate | 20.9% |
| Regions Covered | Global |
